Initial reports show that there has not been a single COVID-related death among any of the patients who received the monoclonal antibody infusions. More data is increasingly emerging from several doctors who treated thousands of COVID patients in high-risk categories — both the elderly, as well as patients with diabetes, high blood pressure, and obesity.
Link to the full story right here.